New Selphyl “Filler” Uses Patient’s Own Blood

Selphyl is a new dermal filler from UBS Aesthetics (Bethlehem, Pa) that allows the natural promotion of cell regeneration and aids in the removal of wrinkles. The FDA-approved product is in limited use around the United States and early reports from physicians claim that the results are as good as a face lift.

Rather than using other dermal fillers, this technology uses the patients own blood to help fill in and build up wrinkles. The patented system enables the preparation of an activated Platelet-rich Fibrin Matrix (PRFM). A small volume of the patient’s blood is collected and the platelets and fibrin are concentrated during a simple centrifuge process. The resulting product — in a liquid, gel, or membrane structure — can be applied to a treatment area of the body to stimulate natural, new tissue growth, according to the company. The resulting product is injected into the treatment area below the surface of the skin.

The technology used to create Selphyl is not new. It’s been around for years for other purposes, such as helping heal sports injuries. It is approved for use on glabella lines, nasolabial folds, acne scars, and postop scars. Cost is estimated at $1,100 for four cubic centimeters.

Source: UBS Aesthetics via Plastic Surgery Practice